Podcast Beta
Questions and Answers
What is the generic name and class of Victoza?
What is the efficacy of Victoza?
Effective in lowering sugars in patients with the use of a GLP-1
What is the nature of the clinical data for Victoza?
A 26-week, double-blind, double-dummy, placebo- and active-controlled, 5-armed, parallel trial.
What is the indication for Victoza?
Signup and view all the answers
Victoza can cause thyroid cancer.
Signup and view all the answers
List some side effects of Victoza.
Signup and view all the answers
What is the initial dosing for Victoza?
Signup and view all the answers
How should Victoza be administered?
Signup and view all the answers
What is the mechanism of action of Victoza?
Signup and view all the answers
What benefit does Victoza provide regarding cardiac events?
Signup and view all the answers
Victoza has poor tolerability with nausea and vomiting.
Signup and view all the answers
What is unique about the Victoza pen?
Signup and view all the answers
What support does the Diabetes Health Coach provide?
Signup and view all the answers
What is the purpose of the blood sugar tracker?
Signup and view all the answers
Eligible patients can pay more than $25 for their Victoza prescription with the Instant Savings Card.
Signup and view all the answers
Study Notes
Victoza Overview
- Generic name: Liraglutide; belongs to the GLP-1 drug class.
- Effective in lowering blood sugar levels in patients using GLP-1.
Clinical Study
- Conducted a 26-week, double-blind, double-dummy trial to evaluate efficacy and safety.
- Included five arms comparing Victoza, rosiglitazone, and placebo, all with glimepiride for type 2 diabetes management.
Indications and Benefits
- Approved for adults with type 2 diabetes to reduce A1c and blood sugar levels.
- Proven to lower the risk of cardiac events.
Safety and Risks
- Potential risk of thyroid cancer associated with Victoza.
- Side effects may include headache, dizziness, gastrointestinal issues, and cold-like symptoms.
Dosing Guidelines
- Initial dose is 0.6 mg per day for one week to mitigate gastrointestinal distress.
- After one week, the dosage should be increased to 1.2 mg for better glycemic control.
Administration
- Administered subcutaneously once daily.
Mechanism of Action
- Liraglutide acts as a long-acting GLP-1 receptor agonist, stimulating insulin secretion by binding to GLP-1 receptors.
Impact on Mortality
- Has the potential to reduce the risk of death from cardiac events in patients with type 2 diabetes.
Patient Tolerability
- Nausea and vomiting are common tolerability challenges in initial treatment phases.
Delivery Devices
- Utilizes a prefilled, disposable Victoza pen that can be dialed to the prescribed dose.
Patient Support
- Offers the Diabetes Health Coach for live and digital support between doctor visits.
- Blood sugar tracker available for patients to share progress with healthcare providers.
Financial Assistance
- Eligible patients can utilize the Victoza Instant Savings Card, limiting costs to $25 for prescriptions.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge about Victoza, including its generic name, drug class, and clinical efficacy. These flashcards will help you understand the important clinical data and effectiveness of Liraglutide as a GLP-1 receptor agonist. Perfect for medical students and healthcare professionals.